Business · 27/01/2012Updated: 10/17/2026 · 1 min read
FDA Approves New Animal Drug for Heartworm Prevention and Parasite Control
Summary
The FDA has approved a new animal drug application submitted by Novartis Animal Health US, Inc. for the use of milbemycin oxime, lufenuron, and praziquantel to prevent heartworm disease, control fleas, and treat internal parasites in dogs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →